TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer

Aberrant activation of beta-catenin/TCF (T-cell factor) signaling is frequently observed in the pancreatic cancer. However, the regulation of nuclear beta-catenin/TCF transcription machinery remains largely unknown. In this study, TFCP2 (transcriptional factor CP2) expression in pancreatic cancer wa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Yuedi, Dai, Yuankun, Cai, Jiaying, Zhao, Han, Liu, Yueqi, Wang, Houbao, Liu, Dexiang, Zhang
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5642575/
https://ncbi.nlm.nih.gov/pubmed/29050300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19741
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars